IT1244879B - Estratti da tessuti animali, utili in terapia e in diagnostica. - Google Patents

Estratti da tessuti animali, utili in terapia e in diagnostica.

Info

Publication number
IT1244879B
IT1244879B IT02234190A IT2234190A IT1244879B IT 1244879 B IT1244879 B IT 1244879B IT 02234190 A IT02234190 A IT 02234190A IT 2234190 A IT2234190 A IT 2234190A IT 1244879 B IT1244879 B IT 1244879B
Authority
IT
Italy
Prior art keywords
administered
substances
diagnostics
therapy
extracts
Prior art date
Application number
IT02234190A
Other languages
English (en)
Other versions
IT9022341A0 (it
IT9022341A1 (it
Inventor
Alberto Bartorelli
Angela Turiano
Original Assignee
Alberto Bartorelli
Angela Turiano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alberto Bartorelli, Angela Turiano filed Critical Alberto Bartorelli
Publication of IT9022341A0 publication Critical patent/IT9022341A0/it
Priority to IT02234190A priority Critical patent/IT1244879B/it
Priority to HU9301677A priority patent/HU217615B/hu
Priority to KR1019930701728A priority patent/KR100196028B1/ko
Priority to CA002098113A priority patent/CA2098113C/en
Priority to DE69110060T priority patent/DE69110060T2/de
Priority to EP92900285A priority patent/EP0574394B1/en
Priority to AT92900285T priority patent/ATE122890T1/de
Priority to RU93042874A priority patent/RU2113224C1/ru
Priority to AU90357/91A priority patent/AU661287B2/en
Priority to PCT/EP1991/002354 priority patent/WO1992010197A1/en
Priority to JP50037392A priority patent/JP3213942B2/ja
Priority to DK92900285.5T priority patent/DK0574394T3/da
Priority to CS931116A priority patent/CZ283037B6/cs
Priority to ES92900285T priority patent/ES2073277T3/es
Publication of IT9022341A1 publication Critical patent/IT9022341A1/it
Priority to NO932101A priority patent/NO308396B1/no
Application granted granted Critical
Publication of IT1244879B publication Critical patent/IT1244879B/it
Priority to US08/403,121 priority patent/US5824640A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT02234190A 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica. IT1244879B (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.
AU90357/91A AU661287B2 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy
JP50037392A JP3213942B2 (ja) 1990-12-11 1991-12-09 ヒトの治療に有用なポリペプチド性物質
CA002098113A CA2098113C (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy
DE69110060T DE69110060T2 (de) 1990-12-11 1991-12-09 In der humantherapie nützliche substanzen peptidischer natur.
EP92900285A EP0574394B1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy
AT92900285T ATE122890T1 (de) 1990-12-11 1991-12-09 In der humantherapie nützliche substanzen peptidischer natur.
RU93042874A RU2113224C1 (ru) 1990-12-11 1991-12-09 Продукт полипептидной природы, способ его получения и фармацевтическая композиция, обладающая противоопухолевой и анальгезирующей активностью
HU9301677A HU217615B (hu) 1990-12-11 1991-12-09 Kecskéből származó fehérjeszármazékok, előállításuk, és ezeket tartalmazó gyógyászati készítmények
PCT/EP1991/002354 WO1992010197A1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy
KR1019930701728A KR100196028B1 (ko) 1990-12-11 1991-12-09 사람의 치료에 유용한 폴리펩티드성 물질
DK92900285.5T DK0574394T3 (da) 1990-12-11 1991-12-09 I den humane terapi anvendelige stoffer af polypeptidnatur
CS931116A CZ283037B6 (cs) 1990-12-11 1991-12-09 Látky polypeptidové povahy, způsob výroby a farmaceutické prostředky s jejich obsahem
ES92900285T ES2073277T3 (es) 1990-12-11 1991-12-09 Sustancias de naturaleza polipeptida utiles en la terapia humana.
NO932101A NO308396B1 (no) 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur
US08/403,121 US5824640A (en) 1990-12-11 1995-03-13 Substances of polypeptide nature useful in human therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.

Publications (3)

Publication Number Publication Date
IT9022341A0 IT9022341A0 (it) 1990-12-11
IT9022341A1 IT9022341A1 (it) 1992-06-11
IT1244879B true IT1244879B (it) 1994-09-12

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.

Country Status (16)

Country Link
US (1) US5824640A (it)
EP (1) EP0574394B1 (it)
JP (1) JP3213942B2 (it)
KR (1) KR100196028B1 (it)
AT (1) ATE122890T1 (it)
AU (1) AU661287B2 (it)
CA (1) CA2098113C (it)
CZ (1) CZ283037B6 (it)
DE (1) DE69110060T2 (it)
DK (1) DK0574394T3 (it)
ES (1) ES2073277T3 (it)
HU (1) HU217615B (it)
IT (1) IT1244879B (it)
NO (1) NO308396B1 (it)
RU (1) RU2113224C1 (it)
WO (1) WO1992010197A1 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
RO117590B1 (ro) * 1995-02-03 2002-05-30 Aeterna Lab Inc Compozitie pentru tratamentul unei degenerari, boli colagenice sau inflamatorii
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
RU2196606C2 (ru) 1996-09-18 2003-01-20 Зетесис С.п.А. Применение белков в качестве агентов против аутоиммунных заболеваний
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
US20030162704A1 (en) * 2000-06-08 2003-08-28 Alberto Panerai Method of treatment of parkison's disease with a protein extractable from mammalian organs
WO2001093888A2 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
RU2211700C2 (ru) * 2001-07-23 2003-09-10 Научно-исследовательский институт медико-биологических проблем Республики Северная Осетия-Алания Способ получения лекарственного препарата "скваакан"
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.
EP1713502A1 (de) * 2004-02-12 2006-10-25 MERCK PATENT GmbH Hochkonzentrierte, flüssige formulierungen von anti-egfr-antikörpern
RU2292393C2 (ru) * 2005-03-03 2007-01-27 Закрытое акционерное общество "Научно-производственное предприятие "Тринита" Способ получения ингибитора коллагеназы из гепатопанкреаса промысловых видов краба

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
EP0149468B1 (de) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
NO932101D0 (no) 1993-06-09
IT9022341A0 (it) 1990-12-11
IT9022341A1 (it) 1992-06-11
CA2098113C (en) 2002-02-05
DE69110060D1 (de) 1995-06-29
KR100196028B1 (ko) 1999-06-15
NO932101L (no) 1993-08-10
AU661287B2 (en) 1995-07-20
JP3213942B2 (ja) 2001-10-02
CZ283037B6 (cs) 1997-12-17
HU9301677D0 (en) 1993-09-28
AU9035791A (en) 1992-07-08
WO1992010197A1 (en) 1992-06-25
CA2098113A1 (en) 1992-06-11
ATE122890T1 (de) 1995-06-15
NO308396B1 (no) 2000-09-11
EP0574394B1 (en) 1995-05-24
CZ111693A3 (en) 1994-04-13
EP0574394A1 (en) 1993-12-22
DK0574394T3 (da) 1995-10-16
HU217615B (hu) 2000-03-28
JPH06504039A (ja) 1994-05-12
HUT64569A (en) 1994-01-28
US5824640A (en) 1998-10-20
ES2073277T3 (es) 1995-08-01
RU2113224C1 (ru) 1998-06-20
DE69110060T2 (de) 1995-09-28

Similar Documents

Publication Publication Date Title
HU9301677D0 (en) Polypeptide-type compounds of medical effect
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
ATE300292T1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
GR1000477B (el) Νεο μονοκλωνικο αντισωμα κατα νεου αντιγονου που σχετιζεται με ανθρωπινους ογκους.
DE69534946D1 (de) Verwendung von nackten Polynukleotiden zur Herstellung eines Medikaments für die Behandlung von Tumoren
DE69807349D1 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
EP0719150A4 (en) CELLULAR VACCINE AND METHODS OF USE FOR TREATING MALIGNAS, SOLID TUMORS
TR200103560T2 (tr) Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı
FI900808A0 (fi) Humant mannos bindande protein.
ATE54826T1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE350474T1 (de) Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird
NZ273258A (en) Immunomodulator composition with components less than 3000 D that are extractable from bile, stimulate monocytes and macrophages and modulate TNF
DK1117783T3 (da) Gen udtrykt i prostatacancer
IL122455A0 (en) Hapten modified tumor cell extract and methods of treating or screening for cancer
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
HU9201197D0 (en) Protection from shock subsequent to injury by double-stranded rns
DE69837935D1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
DK383488A (da) Humant papillomavirus type 41, dets dna og deraf kodede proteiner
EP0136093A3 (en) Anti-cancer factors

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971223